Hep G2 cell line as a human model for sulphate conjugation of drugs

References

• Anderson R. J., Weinshilboum R. M. Phenolsulphotransferase in human tissue: radiochemical enzymatic assay and biochemical properties. Clinica Chimica Acta 1980; 103: 79–90
   PubMed Web of Science ®Google Scholar
• Baranczyk-Kuzma A., Garren J. A., Hidalgo I. J., Borchardt R. T. Substrate specificity and some properties of phenol sulfotransferase from intestinal Caco-2 cells. Life Sciences 1991; 49: 1197–1206
   PubMed Web of Science ®Google Scholar
• Campbell N. R. C., Van Loon J. A., Weinshilboum R. M. Human liver phenolsulfo-transferase: assay conditions, biochemical properties and partial purification of isoenzymes of the thermostable form. Biochemical Pharmacology 1987a; 36: 1435–1446
   PubMed Web of Science ®Google Scholar
• Campbell N. R. C., Van Loon J. A., Sundaham R. S., Ames M. M., Hansch C., Weinshilboum R. Human and rat liver phenol sulfotransferase: structure-activity relationships for phenolic substrates. Molecular Pharmacology 1987b; 32: 813–819
   PubMed Web of Science ®Google Scholar
• Dawson J. R., Adams D. J., Wolf C. R. Induction of drug metabolizing enzymes in human liver cell line Hep G2. FEBS Letters 1985; 183: 219–222
   PubMed Web of Science ®Google Scholar
• Doostdar H., Demoz A., Burke M. D., Melvin W. T., Grant M. H. Variation in drug-metabolizing enzyme activities during the growth of human Hep G2 hepatoma cells. Xenobiotica 1990; 20: 435–441
   PubMed Web of Science ®Google Scholar
• Falany C. N. Molecular enzymology of human liver cytosolic sulfotransferases. Trends in Pharmacological Sciences 1991; 12: 255–259
   PubMed Web of Science ®Google Scholar
• Fischer V., Wiebel F. J. Metabolism of fluperlapine by cytochrome P450-dependent and flavin-dependent monooxygenases in continuous cultures of rat and human cells. Biochemical Pharmacology 1990; 39: 1327–1333
   PubMed Web of Science ®Google Scholar
• Foldes A., Meek J. L. Rat brain phenolsulfotransferase—partial purification and some properties. Biochimica Biophysica Acta 1973; 327: 365–374
   PubMed Web of Science ®Google Scholar
• Grant M. H., Burke M. D., Hawksworth G. M., Duthie S. J., Engeset J., Petrie J. C. Human adult hepatocytes in primary monolayer culture—maintenance of mixed function oxidase and conjugation pathways of drug metabolism. Biochemical Pharmacology 1987; 36: 2311–2316
   PubMed Web of Science ®Google Scholar
• Grant H. M., Duthie S. J., Gray A. G., Burke M. D. Mixed function oxidase and UDP-glucuronyltransferase activities in the human Hep G2 hepatoma cell line. Biochemical Pharmacology 1988; 37: 4111–4116
   PubMed Web of Science ®Google Scholar
• Grant M. H., Hawksworth G. M. The activity of UDP-glucuronyltransferase, sulfo-transferase and glutathione-S-transferase in primary cultures of rat hepatocytes. Biochemical Pharmacology 1986; 35: 2979–2982
   PubMed Web of Science ®Google Scholar
• Kienzl E., Eichinger K. Preparation of dopamine 3-O-sulphate and dopamine 4-O-sulphate as reference substances and high-performance liquid chromatographic trace determination. Journal of Chromatography 1988; 430: 263–269
   PubMedGoogle Scholar
• Liu M. C., Yu S., Suiko M. Tyramine-O-sulfate, in addition to tyrosine-O-sulfate, is produced and secreted by Hep G2 human hepatoma cells, but not by 3Y1 rat embryo fibroblasts. Biochemistry International. 1990; 21: 815–821
   PubMedGoogle Scholar
• Lowry O. H., Rosebrough N. J., Farr A., Randall R. J. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 1951; 193: 265–275
   PubMed Web of Science ®Google Scholar
• Mulder G. J. Sulfation of Drugs and Related Compounds. CRC Press, Boca Raton, FLUSA 1981
   Google Scholar
• Mulder G. J., Jakoby W. B. Sulfation. Conjugation Reactions in Drug Metabolism: An Integrated Approach. Substrates, Co-substrates, Enzymes and Their Interactions In Vivo and In Vitro, G. J. Mulder. Taylor & Francis, London 1990; 107–161
   Google Scholar
• Nimura N., Ogura H., Kinoshita T. Reversed-phase liquid chromatographic resolution of amino acid enantiomers by derivatization with 2,3,4,6-tetra-O-β-D-glucopyranosyl isothio-cyanate. Journal of Chromatography 1980; 202: 375–379
   Web of Science ®Google Scholar
• Oatis J. E., Jr., Russell M. P., Knapp D. R., Walle T. Ring-hydroxylated propranolol: synthesis and β-receptor antagonist and vasodilating activities of the seven isomers. Journal of Medicinal Chemistry 1981; 24: 309–314
   PubMed Web of Science ®Google Scholar
• Oatis J. E., Jr., Walle T., Daniell H. B., Gaffney T. E., Knapp D. R. Synthesis of 4′-hydroxypropranolol sulfate, a major non-β-blocking propranolol metabolite in man. Journal of Medicinal Chemistry 1985; 28: 822–824
   PubMed Web of Science ®Google Scholar
• Patel D. K., Shockcor J. P., Chang S. Y., Sigel C. W., Huber B. E. Metabolism of a novel antitumor agent, crisnatol, by a human hepatoma cell line, Hep G2, and hepatic microsomes. Biochemical Pharmacology 1991; 42: 337–346
   PubMedGoogle Scholar
• Rein G., Glover V., Sandler M. Multiple forms of phenolsulphotransferase in human tissues. Selective inhibition by dichloronitrophenol. Biochemical Pharmacology 1982; 31: 1893–1897
   PubMed Web of Science ®Google Scholar
• Reiter C., Mwaluko G., Dunnette J., Van Loon J., Weinshilboum R. Thermolabile and thermostable human platelet phenol sulfotransferase. Substrate specificity and physical separation. Naunyn-Schmiedeberg's Archives of Pharmacology 1983; 324: 140–147
   PubMed Web of Science ®Google Scholar
• Sassa S., Sugita O., Galbraith R. A., Kappas A. Drug metabolism by the human hepatoma cell, Hep G2. Biochemical and Biophysical Research Communications 1987; 143: 52–57
   PubMed Web of Science ®Google Scholar
• Steiner A., Walle U. K., Walle T. Induction of propranolol metabolism in the Hep G2 human hepatoma cell line. Journal of Pharmacy and Pharmacology 1992, accepted for publication
   Google Scholar
• Sundaram R. S., Szumlanski C., Otterness D., Van Loon J. A., Weinshilboum R. M. Human intestinal phenol sulfotransferase: assay conditions, activity levels and partial purification of the thermolabile form. Drug Metabolism and Disposition 1989; 17: 255–264
   PubMed Web of Science ®Google Scholar
• Walle T., Walle U. K. Stereoselective sulphate conjugation of racemic terbutaline by human liver cytosol. British Journal of Clinical Pharmacology 1990; 30: 127–133
   PubMed Web of Science ®Google Scholar
• Walle T., Walle U. K. Stereoselective sulfate conjugation of racemic 4-hydroxypropranolol by human and rat liver cytosol. Drug Metabolism and Disposition 1991a; 19: 448–453
   PubMed Web of Science ®Google Scholar
• Walle T., Walle U. K. Stereoselective sulfate conjugation of 4-hydroxypropranolol and terbutaline by the human liver phenolsulfotransferases. Drug Metabolism and Disposition 1992; 20: 333–336
   PubMed Web of Science ®Google Scholar
• Walle U. K., Walle T. Stereoselective sulfate conjugation of 4-hydroxypropranolol in humans: comparison of platelet and hepatic activity. Drug Metabolism and Disposition 1991b; 19: 838–840
   PubMedGoogle Scholar
• Weinshilboum R. M. Phenol sulfotransferase in humans: properties, regulation, and function. Federation Proceedings 1986; 45: 2223–2228
   PubMedGoogle Scholar
• Whittemore R. M., Pearce L. B., Roth J. A. Purification and kinetic characterization of a dopamine-sulfating form of phenol sulfotransferase from human brain. Biochemistry 1985; 24: 2477–2482
   PubMed Web of Science ®Google Scholar
• Young W. F., Okazaki H., Laws E. R., Jr., Weinshilboum R. M. Human brain phenol sulfotransferase: biochemical properties and regional localization. Journal of Neurochemistry 1984; 43: 706–715
   PubMed Web of Science ®Google Scholar